Evidence map›Paper›PMID 35873109›Full record

ReviewEnergy & fuels : an American Chemical Society journal2021

Recent Advances and Perspectives in Photodriven Charge Accumulation in Molecular Compounds: A Mini Review.

Tobias H Bürgin, Oliver S Wenger

Abstract readReview
In one paragraph

Review in Energy & fuels : an American Chemical Society journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Accumulation of Four Electrons on a Terphenyl (Bis)disulfide.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tobias H BürginDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056 Basel, Switzerland.
Oliver S WengerDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056 Basel, Switzerland.ORCID https://orcid.org/0000-0002-0739-0553

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The formation of so-called solar fuels from abundant low-energetic compounds, such as carbon dioxide or water, relies on the chemical elementary steps of photoinduced electron transfer and accumulation of multiple redox equivalents. The majority of molecular systems explored to date require sacrificial electron donors to accumulate multiple electrons on a single acceptor unit, but the use of high-energetic sacrificial redox reagents is unsustainable. In recent years, an increasing number of molecular compounds for reversible light-driven accumulation of redox equivalents that do not need sacrificial electron donors has been reported. Those compounds are the focus of this mini review. Different concepts, such as redox potential compression (achieved by proton-coupled electron transfer, Lewis acid-base interactions, or structural rearrangements), hybrids with inorganic nanoparticles, and diffusion-controlled multi-component systems, will be discussed. Newly developed strategies to outcompete unproductive reaction pathways in favor of desired photoproduct formation will be compared, and the importance of identifying reaction intermediates in the course of multiphotonic excitation by different time-resolved spectroscopic techniques will be discussed. The mechanistic insights gained from molecular donor-photosensitizer-acceptor compounds inform the design of next-generation charge accumulation systems for solar energy conversion.

Identifiers

PMID35873109
PMCPMC9302442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.